Detroit-based Caraco Pharmaceutical Laboratories Ltd. has announced that its generic drug Methimazole has been granted final approval by U.S. health. The tablet used for treatment of hyperthyroidism will be sold in 5mg and 10mg strengths by the company under brand name Northyx.

Chennai: Cadila Healthcare Ltd has received USFDA approval for hydroxychloroquine sulphate tabs in the strength of 200 mg.

The medicine falls under the DMARD (disease modifying anti-rheumatic drug) section, and is used in caring rheumatoid arthritis.

According to NDC Health, the sales of such pills in the US market in 2006 stood at $30 million.

London: GlaxoSmithKline PLC’s cervical cancer vaccine ‘Cervarix’ has received nod for sale across the European Union.

The vaccine has been sanctioned to avert pre-cancerous wounds and cervical cancer caused by human papillomavirus types 16 and 18 that held responsible for over 70 per cent of all cervical cancer cases.

The world’s second-biggest drug manufacturer said that the indication for Cervarix is based on statistics developed by clinical studies in girls and young women between 10 and 25.

Bangalore: Biocon Ltd has displayed the outcomes of phase-I studies on its oral insulin product, IN-105, at the European Association for Study of Diabetes conference held in Amsterdam on Friday.

Washington, September 14: Chemists at the University of Nottingham are using green chemistry techniques for coating drugs in plastics, which may provide an effective delivery system for the cutting-edge drugs.

The researchers say that with their technique, the bioactive elements of the drug remain completely effective, which is why it may provide the maximum benefit of the therapy to patients.